Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203922

« Back to Dashboard

NDA 203922 describes SODIUM NITRITE, which is a drug marketed by Hope Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the SODIUM NITRITE profile page.

The generic ingredient in SODIUM NITRITE is sodium nitrite. There are one thousand four hundred and fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium nitrite profile page.
Summary for 203922
Applicant:Hope Pharms
Ingredient:sodium nitrite
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 203922
Suppliers and Packaging for NDA: 203922
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922 NDA Hope Pharmaceuticals 60267-311 60267-311-10 10 mL in 1 VIAL, SINGLE-USE (60267-311-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength300MG/10ML (30MG/ML)
Approval Date:Feb 14, 2012TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 14, 2018
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:➤ SubscribePatent Expiration:Dec 24, 2031Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
Argus Health
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.